NL-OMON49527招募中不适用
STOPPING OF DISEASE MODIFYING TREATMENTS AND OLIGOCLONAL BANDS IN PEOPLE WITH MULTIPLE SCLEROSIS - STOP-MS
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Diagnosis MS according to Poser or any version of the McDonald criteria.
- •Age >=45 years of age;
- •Treatment with interferon beta, glatiramer acetate, dimethyl fumarate or
- •teriflunomide;
- •Absence of relapses within the previous 5 years;
- •Absence of active MRI lesions (new T2 lesions compared to MRI <=2 years ago
- •OR gadolinium enhancing T2 lesions);
- •Opportunity to provide written informed consent.
排除标准
- •Use of oral anticoagulants OR clopidogrel as platelet aggregation inhibitor;
- •Any other contra-indication for a lumbar punction;
- •Unwillingness to undergo a lumbar and/or venous puncture.
研究者
相似试验
进行中（未招募）
1 期
Disease modifying therapies withdrawal in inactive Secondary Progressive Multiple Sclerosis patients older than 50 yearsMedDRA version: 20.0 Level: PT Classification code 10063400 Term: Secondary progressive multiple sclerosis System Organ Class: 10029205 - Nervous system disordersSecondary Progressive Multiple SclerosisEUCTR2018-001292-21-FRCHU de Rennes250
进行中（未招募）
1 期
Discontinuation of first-line disease modifying treatment (DMT) in long-term full responders MS patientsRelapsing-Remitting multiple sclerosis (RR-MS),MedDRA version: 21.1Level: PTClassification code 10063399Term: Relapsing-remitting multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2016-004819-12-ITOSPEDALE SAN RAFFAELE300
已完成
不适用
Reduction of potentially inappropriate medication in the elderypotentially inappropriate medication in the elderly (no specific disease or condition necessary for study inclucion)DRKS00003610Ruhr-Universität Bochum1,275
进行中（未招募）
1 期
Withdrawal of pharmacological treatment in patients responding to cardiac resynchronization therapy: Open and randomized studyHeart failureEUCTR2021-001327-41-ESFundación para la formación e investigación sanitarias de la Región de Murcia60
招募中
不适用
Discontinuation of biological agents without functional and structural damage progression after attaining sustained remission in patients with rheumatoid arthritisRheumatoid ArthritisJPRN-UMIN000022596Department of Hematology and Rheumatology, Kinki University School of Medicine110